Structure-activity relationships of carbocyclic influenza neuraminidase inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 14, 1997, Pages 1837-1842

  Williams, Matthew A ^a   Lew, Willard ^a   Mendel, Dirk B ^a   Tai, Chun Y ^a   Escarpe, Paul A ^a   Laver, W Graeme ^b   Stevens, Raymond C ^c   Kim, Choung U ^a  

^a GILEAD SCIENCES   (United States)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; OSELTAMIVIR; SIALIDASE; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CRYSTAL STRUCTURE; CYTOPATHOGENIC EFFECT; DRUG ACTIVITY; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; HYDROPHOBICITY; IN VITRO STUDY; INFLUENZA VIRUS A; INFLUENZA VIRUS B; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

INFLUENZA VIRUS; INFLUENZAVIRUS A; INFLUENZAVIRUS B;

EID: 0030800108     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)00333-8     Document Type: Article

References (20)

1. (a) Ryan, D. M.; Ticehurst, J.; Demsey, M. H.; Penn, C. R. Antimicrob. Agents Chemother. 1994, 38, 2270.
2. (b) Ryan, D. M.; Ticehurst, J.; Demsey, M. H.; Penn, C. R. Antimicrob. Agents Chemother. 1995, 39, 2583
3. Liu, C.; Eichelberger, M. C.; Compans, R. W.; Air G. M. J. Virol. 1995, 69, 1099.
4. Hayden, F. G.; Treanor, J. J.; Esinhart, J.; Eason C. U.; Hussey, E. K. Antiviral Res. 1995, 26/3. A 300 (Abst. 140).
5. Wood, J. M.; Bethell, R. C., Bethell, R. C.; Coates, J. A.; Healy, N.; Hiscox, S. A.; Pearson, B. A.; Ryan, D. M.; Ticehurst, J.; Tilling, J.; Walcott, S. M.; Penn, C. R. Antimicrob. Agents Chemother. 1993 37, 1473.
6. Hayden, F. G.; Treanor, J. J.; Betts, R. F.; Lobo, M.; Esinhart, J.; Hussey J. Amer. Med. Assoc. 1996, 275, 295.
7. (a) Kim, C. U.; Lew, W.; Williams, M. A.; Liu, H.; Zhang, L.; Swaminathan, S.; Bischofberger, N.; Chen, M. S.; Mendel, D. B.; Tai, C. Y.; Laver, W. G.; Stevens, R. C. J. Am. Chem. Soc. 1997, 119, 681.
8. (b) Kim, C. U.; Lew, W.; Williams, M. A.; Zhang, L.; Swaminathan, S.; Bischofberger, N.; Chen, M. S.; Mendel, D. B.; Li, W.; Tai, L.; Escarpe, P.; Cundy, K. C.; Eisenberg, E. J.; Lacy, S.; Sidwell, R. W.; Stevens, R. C.; Laver, W. G. 1996. New Potent, Orally Active Neuraminidase Inhibitors as Anti-Influenza Agents, abstr. H44, p 171. In Program and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, Washington, D.C.
9. Taylor, N. R.; von Itzstein, M. J. Med. Chem. 1994, 37, 616.
10. (a) Sollis, S. L.; Howes, P. D.; Smith, P. W.; Cherry, P. C.; Bethell, R. C. Bioorg. Med. Chem. Lett. 1996, 6, 1805.
11. (b) Smith, P. W.; Sollis, S. L.; Howes, P. D.; Cherry, P. C.; Cobley, K. N.; Taylor, H.; Whittington, A. R.; Scicinski, J.; Bethell, R. C.; Taylor, N.; Skarzynski, T.; Cleasby, A.; Singh, O.; Wonacott, A.; Varghese, J.; Colman, P. Bioorg. Med. Chem. Lett. 1996, 6, 2931.
12. Chandler, M.; Conroy, R.; Cooper, A. W. J.; Lamont, R. B.; Scicinski, J. J.; Smart, J. E.; Storer, R.; Weir, N. G.; Wilson, R. D.; Wyatt, P. G. J. Chem. Soc. Perkin Trans. 1 1995, 1189.
13. Ohme, R.; Schmitz, E. Angew. Chem. Intl. Ed. Engl. 1967, 6, 566.
14. (a) Poss, M. A.; Iwanowicz, E.; Reid, J. A.; Lin, J.; Gu, Z. Tetrahedron Lett. 1992, 33, 5933.
15. (b) Preparation of N,N'-bis-tert-butoxycarbonylthiourea: Iwanowicz, E.; Poss, M. A.; Lin, J. Synthetic Commun. 1993, 23, 1443.
16. A full protocol for the enzymatic and plaque reduction biological assays is described in ref 6a.
17. von Itzstein, M.; Wu, W-Y.; Kok, G. B.; Pegg, M. S.; Dyason, J. C.; Jin, B.; Phan, T. V.; Smythe, M. L.; White, H. F.; Oliver, S. W.; Colman, P. M.; Varghese, J. N.; Ryan, D. M.; Wood, J. M.; Bethell, R. C.; Hotham, V. J.; Cameron, J. M.; Penn, C. R. Nature (London) 1993, 363, 418.
18. Starkey, I. D.; Mahmoudian, M.; Noble, D.; Smith, P. W.; Cherry, P. C.; Howes, P. D.; Sollis, S. L.; Tetrahedron Lett. 1995, 36, 299.
19. Smith, P. W.; Starkey, I. D.; Howes, P. D.; Sollis S. L.; Keeling, S. P.; Cherry, P. C.; von Itzstein, M.; Wu, W. Y.; Jin, B. Eur. J. Med. Chem. 1996, 31, 143.
20. A full account of structure-activity relationships of carbocyclic neuraminidase inhibitors related to 1a will be published separately.